UTSA researchers receive boost with technology from German biosciences company

UTSA Vice President for Research Mauli Agrawal and Cytocentrics CEO Dr. Jim Garvin

UTSA Vice President for Research Mauli Agrawal and Cytocentrics CEO Dr. Jim Garvin

Share this Story

(June 12, 2015) – The Center for Innovative Drug Discovery (CIDD), a joint venture between UTSA and the University of Texas Health Science Center at San Antonio (UTHSCSA), has entered into a research development partnership with German-based company Cytocentrics Biosciences.

The partnership has significant potential impact for drug discovery research across multiple therapeutic disciplines, and will benefit several departments at both institutions. It also complements UTSA’s drive to Tier One status by creating opportunities for excellence in education and research.

The CIDD launched in 2012 with $3.5 million in funding and provides expertise and core services to spur the development of pre-clinical drug candidates. In Fall 2014, center researchers Stanton McHardy and Rong Li received $1.9 million from the Cancer Prevention & Research Institute of Texas to develop next-generation breast cancer treatment drugs.

The unique research center is composed of a 2,000 square-foot, state-of-the-art Medicinal Chemistry and Synthesis Core Facility on the UTSA West Campus. The technological center provides chemistry and synthesis services to support small molecule drug discovery efforts. The center also includes a High-Throughput Screening Facility at the UT Health Science Center.

Cytocentrics has agreed to donate two Cytopatch machines to the CIDD that will enable researchers to advance novel therapies in the areas of biochemistry, physiology and neuroscience. Cytocentrics manufactures the CytoPatch machine, which automates a medical “patch clamp” technique that looks at cell membranes to determine how they will react to different drugs.

Over the long term, the donation will help CIDD researchers train students and could make them more competitive for extramural funding.

This week, Cytocentrics announced it was relocating its corporate headquarters and operatons to San Antonio after City Council members approved a one million grant over five years. As part of the city's agreement with the company, Cytocentrics will invest $15 million and create 300 high-wage jobs with an average salary of $70,000.

“San Antonio is known for its collaborative spirit. Cytocentrics’ relocation to San Antonio serves as an example of how the private sector, academia and the City can partner together to enable progress, drive innovation and ultimately create more jobs,” said Mauli Agrawal, UTSA Vice President for Research.

Learn more about the Center for Innovative Drug Discovery.

Connect online with UTSA on Twitter, Facebook, YouTube and Instagram.

 

 

Events



Spotlight

UTSA Bold Promise CTA

UTSA’s Mission

The University of Texas at San Antonio is dedicated to the advancement of knowledge through research and discovery, teaching and learning, community engagement and public service. As an institution of access and excellence, UTSA embraces multicultural traditions and serves as a center for intellectual and creative resources as well as a catalyst for socioeconomic development and the commercialization of intellectual property - for Texas, the nation and the world.

UTSA’s Vision

To be a premier public research university, providing access to educational excellence and preparing citizen leaders for the global environment.

UTSA’s Core Values

We encourage an environment of dialogue and discovery, where integrity, excellence, inclusiveness, respect, collaboration and innovation are fostered.

UTSA’S Destinations

UTSA is a proud Hispanic Serving Institution (HSI) as designated by the U.S. Department of Education .

Our Commitment to Inclusivity

The University of Texas at San Antonio, a Hispanic Serving Institution situated in a global city that has been a crossroads of peoples and cultures for centuries, values diversity and inclusion in all aspects of university life. As an institution expressly founded to advance the education of Mexican Americans and other underserved communities, our university is committed to promoting access for all. UTSA, a premier public research university, fosters academic excellence through a community of dialogue, discovery and innovation that embraces the uniqueness of each voice.